Identification of selenium-containing benzamides as potent microtubule-targeting antitumor agents
Bioorganic Chemistry · 2025
DOI: 10.1016/j.bioorg.2025.108355 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2025. Verfasst von Bin Jiang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China; Department of Phar…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Microtubules, Benzamides, Tubulin Modulators. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Natural Science Foundation of Beijing Municipality, Hebei Provincial Natural Science Foundation, Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
IMB5046, a microtubule inhibitor discovered by our team, served as the lead compound for designing a series of selenium-containing benzoates and benzamides. Among these, compound 2g emerged as a lead candidate, demonstrating potent antiproliferative activity. Mechanistic studies revealed that 2g bound to the colchicine site of tubulin, caused G2/M cell cycle arrest, and generated ROS. Notably, 2g exhibited exceptional efficacy in P-gp overexpressing MCF7/ADR and KBV200 cell lines, with drug-resistance indices (DRI) of 0.83 and 0.58, respectively, significantly outperforming colchicine (DRIs: 25.4 and 8.03) and paclitaxel (DRIs: 41.0 and 4.96). In an MCF-7 xenograft model, 2g (25 mg/kg, IP) achieved a tumor growth inhibition rate of 57.2 %, surpassing IMB5046 (47.6 %). To enhance solubility and pharmacokinetics, prodrug 2g-P was developed, showing 69 % bioavailability but reduced in vivo efficacy. Further investigation is warranted to elucidate the factors underlying the discrepancy, such as the efficiency of prodrug-to-drug conversion and intracellular accumulation of active 2g. In summary, our study not only identified a novel selenium-containing lead compound, but also provided important insights into prodrug design. These findings lay a solid foundation for the development of next-generation microtubule-targeting agents capable of overcoming drug resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China; Department of Pharmaceutical Chemistry, School of Pharmacy, Hebei Medical University, Sh…
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
- Department of Pharmaceutical Chemistry, School of Pharmacy, Hebei Medical University, Shijiazhuang 050017, China.
- Department of Pharmacy, Medical Supplies Center of PLA General Hospital, China.
- Department of Pharmaceutical Chemistry, School of Pharmacy, Hebei Medical University, Shijiazhuang 050017, China. Electronic address: 18100956@hebmu.edu.cn.
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. Electronic address: lvkai@imb.pumc.edu.cn.
Förderung
- Natural Science Foundation of Beijing Municipality
- Hebei Provincial Natural Science Foundation
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
Zitieren
APA
Jiang, B., Zheng, Y., Xue, T., Wu, J., Song, H., Zhou, S., Li, Y., Gong, J., Wei, M., Ji, X., Wei, M., Wang, L., Gong, J., Liu, M., Wang, A., Zhang, K., Lv, K., & Zheng, Y. (2025). Identification of selenium-containing benzamides as potent microtubule-targeting antitumor agents. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2025.108355
Vancouver
Jiang B, Zheng Y, Xue T, Wu J, Song H, Zhou S, et al. Identification of selenium-containing benzamides as potent microtubule-targeting antitumor agents. Bioorganic Chemistry. 2025. doi:10.1016/j.bioorg.2025.108355
BibTeX
@article{Jiang2025,
author = {Jiang, Bin and Zheng, Yijia and Xue, Tiezheng and Wu, Jizhou and Song, Huijuan and Zhou, Sheng and Li, Yujing and Gong, Jiaqi and Wei, Meng and Ji, Xiaorui and Wei, Meijiao and Wang, Lujun and Gong, Jianhua and Liu, Mingliang and Wang, Apeng and Zhang, Kai and Lv, Kai and Zheng, Yanbo},
title = {Identification of selenium-containing benzamides as potent microtubule-targeting antitumor agents},
journal = {Bioorganic Chemistry},
year = {2025},
doi = {10.1016/j.bioorg.2025.108355}
}
EUVIMED